MedPath
FDA Approval

Diphenoxylate Hydrochloride and Atropine Sulfate

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
March 30, 2022
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Atropine(0.025 mg in 1 1)
Diphenoxylate(2.5 mg in 1 1)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

RPK Pharmaceuticals, Inc.

RPK Pharmaceuticals, Inc.

147096275

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Diphenoxylate Hydrochloride and Atropine Sulfate

Product Details

NDC Product Code
53002-3401
Application Number
ANDA213413
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
February 25, 2020
AtropineActive
Code: 03J5ZE7KA5Class: ACTIBQuantity: 0.025 mg in 1 1
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4Class: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5XClass: IACT
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61UClass: IACT
STARCH, CORNInactive
Code: O8232NY3SJClass: IACT
STEARIC ACIDInactive
Code: 4ELV7Z65APClass: IACT
Code: W24OD7YW48Class: ACTIBQuantity: 2.5 mg in 1 1
© Copyright 2025. All Rights Reserved by MedPath